Table 3.
Age, y | No. | Complete remission |
Resistant disease |
Overall survival at 5 y* |
Relapse-free survival at 5 y† |
Disease-free survival at 5 y‡ |
|||||
---|---|---|---|---|---|---|---|---|---|---|---|
% | 95% CI, % | % | 95% CI, % | Estimate | 95% CI, % | Estimate | 95% CI, % | Estimate | 95% CI, % | ||
15 to 29 | 86 | 87 | 78-93 | 3 | 1-10 | 39 | 27-49 | 32 | 21-43 | 48 | 31-65 |
30 to 49 | 71 | 80 | 69-89 | 14 | 7-24 | 32 | 21-43 | 29 | 17-41 | 40 | 23-58 |
50 to 65 | 43 | 63 | 47-77 | 19 | 8-33 | 23 | 11-36 | 22 | 7-38 | 25 | 4-46 |
Five years after study entry.
Five years after complete remission.
Five years after start of maintenance chemotherapy (maintenance patients only).